24
Views
2
CrossRef citations to date
0
Altmetric
Patent Evaluation

Fused thiazole derivatives having affinity for the histamine H3 receptor

Glaxo Group Limited: WO2006097691

Pages 129-131 | Published online: 03 Jan 2007
 

Abstract

A group of structurally related thiazoloazepines displaying high affinity for histamine receptors of the H3 subtype, with pKi values in the range of 7.5 – 9.5, are disclosed in the latest of a series of such applications from Glaxo. These compounds have potential utility in the treatment of CNS disorders, in particular for the improvement of cognitive deficits and alleviation of some symptoms of Alzheimer’s disease, when administered either alone or in combination with other psychotherapeutic agents, for example, muscarinic M1 agonists or acetylcholinesterase inhibitors.

Patent details

  • Title Fused thiazole derivatives having affinity for the histamine H3 receptor

  • Assignee Bailey N, Pickering PL,Wilson DM

  • Inventors Glaxo Group Ltd

  • Priority date 14/03/05

  • Filing date 10/03/06

  • Publication date 21/09/06

  • Publication no. WO2006097691

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.